AMAT vs VRT: Which Is the Better Buy?

Side-by-side comparison of Applied Materials, Inc. and Vertiv Holdings Co β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-26.
Applied Materials, Inc. Β· Technology
$474.38
-3.5% upside to fair value
Med Conviction Grade C High Quality
VS
Vertiv Holdings Co Β· Industrials
$253.28
+8.2% upside to fair value
Med Conviction Grade C High Quality
QuantHub Verdict
VRT has more upside to fair value (+8.2%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric AMAT VRT
Current Price $474.38 $253.28
Fair Value Estimate $457.95 $274.15
Upside to Fair Value -3.5% +8.2%
Market Cap $376.6B $97.5B
Forward P/E β€” β€”
EV / EBITDA 33.1x 38.8x
Price / Sales 12.2x 8.5x
Price / FCF 67.0x 33.3x
Revenue Growth YoY +24.8% +24.1%
Gross Margin 49.4% 37.5%
Operating Margin 30.5% 19.1%
Return on Equity 40.4% 42.1%
Dividend Yield 0.42% 0.1%
FCF Yield 1.49% 3.0%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
AMAT β€” Applied Materials, Inc.
Applied Materials is the largest supplier of wafer fabrication equipment, providing deposition, etch, ion implantation, and process-control tools alongside a growing Applied Global Services aftermarket business to semiconductor manufacturers worldwide. The business quality is high: TTM gross margin of 49.4%, TTM operating margin of 30.5%, TTM net margin of 30.1%, and ROE of 40.4% reflect a durabl…
VRT β€” Vertiv Holdings Co
Vertiv Holdings Co is a global provider of critical digital infrastructure for data centers, communication networks, and industrial applications, spanning AC and DC power management, thermal cooling, integrated rack systems, and lifecycle services under brands including Liebert, NetSure, Geist, and Avocent, with roughly 34,000 employees and a global footprint across the Americas, Asia Pacific, an…
Accumulation Zones
Metric AMAT VRT
Zone Low $343.46 $205.61
Zone High $389.26 $233.03
In Buy Zone? No No
← AMAT Research    VRT Research β†’    All Research